1	Characterization	Characterization	B-NP	NN	O	12	NMOD	0
2	of	of	B-PP	IN	O	1	NMOD	0
3	the	the	B-NP	DT	O	5	NMOD	0
4	metabolic	metabolic	I-NP	JJ	O	5	NMOD	0
5	changes	change	I-NP	NNS	O	2	PMOD	0
6	underlying	underlie	B-VP	VBG	O	5	NMOD	0
7	growth	growth	B-NP	NN	B-protein	8	NMOD	0
8	factor	factor	I-NP	NN	I-protein	10	NMOD	0
9	angiogenic	angiogenic	I-NP	JJ	O	10	NMOD	3	angiogenic
10	activation	activation	I-NP	NN	O	6	OBJ	17	activation
11	:	:	O	:	O	1	P	0
12	identification	identification	B-NP	NN	O	0	ROOT	0
13	of	of	B-PP	IN	O	12	NMOD	0
14	new	new	B-NP	JJ	O	16	AMOD	0
15	potential	potential	I-NP	JJ	O	16	AMOD	0
16	therapeutic	therapeutic	I-NP	JJ	O	17	NMOD	0
17	targets	target	I-NP	NNS	O	13	PMOD	0
18	.	.	O	.	O	12	P	0

1	Angiogenesis	Angiogenesis	B-NP	NN	O	2	SUB	3	Angiogenesis
2	is	be	B-VP	VBZ	O	0	ROOT	0
3	a	a	B-NP	DT	O	5	NMOD	0
4	fundamental	fundamental	I-NP	JJ	O	5	NMOD	0
5	process	process	I-NP	NN	O	2	PRD	0
6	to	to	B-PP	TO	O	5	NMOD	0
7	normal	normal	B-NP	JJ	O	9	AMOD	0
8	and	and	I-NP	CC	O	9	AMOD	0
9	abnormal	abnormal	I-NP	JJ	O	6	PMOD	0
10	tissue	tissue	I-NP	NN	O	11	NMOD	0
11	growth	growth	I-NP	NN	O	9	NMOD	4	growth
12	and	and	I-NP	CC	O	9	NMOD	0
13	repair	repair	I-NP	NN	O	9	NMOD	2	repair
14	,	,	O	,	O	9	P	0
15	which	which	B-NP	WDT	O	9	NMOD	0
16	consists	consist	B-VP	VBZ	O	15	SBAR	0
17	of	of	B-PP	IN	O	16	VMOD	0
18	recruiting	recruit	B-VP	VBG	O	17	PMOD	14	recruiting
19	endothelial	endothelial	B-NP	JJ	B-cell_type	20	NMOD	0
20	cells	cell	I-NP	NNS	I-cell_type	18	OBJ	0
21	toward	toward	B-PP	IN	O	18	VMOD	0
22	an	an	B-NP	DT	O	24	NMOD	0
23	angiogenic	angiogenic	I-NP	JJ	O	24	NMOD	3	angiogenic
24	stimulus	stimulus	I-NP	NN	O	21	PMOD	0
25	.	.	O	.	O	2	P	0

1	The	The	B-NP	DT	O	2	NMOD	0
2	cells	cell	I-NP	NNS	O	4	SUB	0
3	subsequently	subsequently	B-ADVP	RB	O	4	VMOD	0
4	proliferate	proliferate	B-VP	VBP	O	0	ROOT	1	proliferate
5	and	and	O	CC	O	4	VMOD	0
6	differentiate	differentiate	B-VP	VBP	O	4	VMOD	2	differentiate
7	to	to	I-VP	TO	O	8	VMOD	0
8	form	form	I-VP	VB	O	6	VMOD	2	form
9	endothelial	endothelial	B-NP	JJ	O	10	NMOD	0
10	tubes	tube	I-NP	NNS	O	13	NMOD	0
11	and	and	O	CC	O	13	NMOD	0
12	capillary-like	capillary-like	B-NP	JJ	O	13	NMOD	0
13	structures	structure	I-NP	NNS	O	8	OBJ	0
14	.	.	O	.	O	4	P	0

1	Little	Little	B-NP	JJ	O	2	SUB	0
2	is	be	B-VP	VBZ	O	0	ROOT	0
3	known	know	I-VP	VBN	O	2	VC	0
4	about	about	B-PP	IN	O	3	VMOD	0
5	the	the	B-NP	DT	O	7	NMOD	0
6	metabolic	metabolic	I-NP	JJ	O	7	NMOD	0
7	adaptation	adaptation	I-NP	NN	O	4	PMOD	0
8	of	of	B-PP	IN	O	7	NMOD	0
9	endothelial	endothelial	B-NP	JJ	B-cell_type	10	NMOD	0
10	cells	cell	I-NP	NNS	I-cell_type	8	PMOD	0
11	through	through	B-PP	IN	O	7	NMOD	0
12	such	such	B-NP	PDT	O	14	NMOD	0
13	a	a	I-NP	DT	O	14	NMOD	0
14	transformation	transformation	I-NP	NN	O	11	PMOD	2	transformation
15	.	.	O	.	O	2	P	0

1	We	We	B-NP	PRP	O	2	SUB	0
2	studied	study	B-VP	VBD	O	0	ROOT	0
3	the	the	B-NP	DT	O	5	NMOD	0
4	metabolic	metabolic	I-NP	JJ	O	5	NMOD	0
5	changes	change	I-NP	NNS	O	30	NMOD	16	changes
6	of	of	B-PP	IN	O	5	NMOD	0
7	endothelial	endothelial	B-NP	JJ	B-cell_type	9	NMOD	0
8	cell	cell	I-NP	NN	I-cell_type	9	NMOD	0
9	activation	activation	I-NP	NN	O	6	PMOD	17	activation
10	by	by	B-PP	IN	O	5	NMOD	0
11	growth	growth	B-NP	NN	B-protein	12	NMOD	0
12	factors	factor	I-NP	NNS	I-protein	10	PMOD	0
13	using	use	B-VP	VBG	O	5	NMOD	0
14	human	human	B-NP	JJ	B-cell_line	18	NMOD	0
15	umbilical	umbilical	I-NP	JJ	I-cell_line	18	NMOD	0
16	vein	vein	I-NP	NN	I-cell_line	18	NMOD	0
17	endothelial	endothelial	I-NP	JJ	I-cell_line	18	NMOD	0
18	cells	cell	I-NP	NNS	I-cell_line	13	OBJ	0
19	(	(	O	(	O	21	DEP	0
20	HUVECs	HUVEC	B-NP	NNS	B-cell_line	21	DEP	0
21	)	)	O	)	O	18	NMOD	0
22	,	,	O	,	O	30	P	0
23	[	[	B-NP	(	O	30	NMOD	0
24	1	1	I-NP	CD	O	30	NMOD	0
25	,	,	I-NP	,	O	30	P	0
26	2-	2-	I-NP	CD	O	30	NMOD	0
27	(	(	O	(	O	29	DEP	0
28	13	13	B-NP	CD	O	29	DEP	0
29	)	)	O	)	O	26	NMOD	0
30	C	C	B-NP	NN	O	35	NMOD	0
31	(	(	O	(	O	30	NMOD	0
32	2	2	B-NP	CD	O	30	NMOD	0
33	)	)	O	)	O	30	NMOD	0
34	]	]	O	)	O	30	NMOD	0
35	-glucose	-glucose	B-NP	NN	O	40	NMOD	0
36	and	and	I-NP	CC	O	40	NMOD	0
37	mass	mass	I-NP	NN	O	40	NMOD	0
38	isotopomer	isotopomer	I-NP	NN	O	40	NMOD	0
39	distribution	distribution	I-NP	NN	O	40	NMOD	0
40	analysis	analysis	I-NP	NN	O	2	OBJ	0
41	.	.	O	.	O	2	P	0

1	The	The	B-NP	DT	O	2	NMOD	0
2	metabolism	metabolism	I-NP	NN	O	19	SUB	0
3	of	of	B-PP	IN	O	2	NMOD	0
4	[	[	B-NP	(	O	11	NMOD	0
5	1	1	I-NP	CD	O	11	NMOD	0
6	,	,	I-NP	,	O	11	P	0
7	2-	2-	I-NP	CD	O	11	NMOD	0
8	(	(	O	(	O	10	DEP	0
9	13	13	B-NP	CD	O	10	DEP	0
10	)	)	O	)	O	7	NMOD	0
11	C	C	B-NP	NN	O	16	NMOD	0
12	(	(	O	(	O	14	DEP	0
13	2	2	B-NP	CD	O	14	DEP	0
14	)	)	O	)	O	11	NMOD	0
15	]	]	O	)	O	11	NMOD	0
16	-glucose	-glucose	B-NP	NN	O	3	PMOD	0
17	by	by	B-PP	IN	O	2	NMOD	0
18	HUVEC	HUVEC	B-NP	NN	B-cell_line	17	PMOD	0
19	allows	allow	B-VP	VBZ	O	0	ROOT	0
20	us	us	B-NP	PRP	O	22	SUB	0
21	to	to	B-VP	TO	O	22	VMOD	0
22	trace	trace	I-VP	VB	O	19	VMOD	0
23	many	many	B-NP	JJ	O	22	OBJ	0
24	of	of	B-PP	IN	O	23	NMOD	0
25	the	the	B-NP	DT	O	29	NMOD	0
26	main	main	I-NP	JJ	O	29	NMOD	0
27	glucose	glucose	I-NP	NN	O	29	NMOD	0
28	metabolic	metabolic	I-NP	JJ	O	29	NMOD	0
29	pathways	pathway	I-NP	NNS	O	24	PMOD	0
30	,	,	O	,	O	29	P	0
31	including	include	B-PP	VBG	O	29	NMOD	0
32	glycogen	glycogen	B-NP	NN	O	33	NMOD	0
33	synthesis	synthesis	I-NP	NN	O	31	PMOD	8	synthesis
34	,	,	O	,	O	19	P	0
35	the	the	B-NP	DT	O	37	NMOD	0
36	pentose	pentose	I-NP	NN	O	37	NMOD	0
37	cycle	cycle	I-NP	NN	O	41	NMOD	0
38	and	and	O	CC	O	41	NMOD	0
39	the	the	B-NP	DT	O	41	NMOD	0
40	glycolytic	glycolytic	I-NP	JJ	O	41	NMOD	0
41	pathways	pathway	I-NP	NNS	O	19	VMOD	0
42	.	.	O	.	O	19	P	0

1	So	So	O	IN	O	0	ROOT	0
2	we	we	B-NP	PRP	O	3	SUB	0
3	established	establish	B-VP	VBD	O	1	VMOD	0
4	that	that	B-SBAR	IN	O	3	VMOD	0
5	these	these	B-NP	DT	O	6	NMOD	0
6	pathways	pathway	I-NP	NNS	O	7	SUB	0
7	were	be	B-VP	VBD	O	4	SBAR	0
8	crucial	crucial	B-ADJP	JJ	O	7	PRD	0
9	to	to	B-PP	TO	O	8	AMOD	0
10	endothelial	endothelial	B-NP	JJ	B-cell_type	12	NMOD	0
11	cell	cell	I-NP	NN	I-cell_type	12	NMOD	0
12	proliferation	proliferation	I-NP	NN	O	9	PMOD	1	proliferation
13	under	under	B-PP	IN	O	12	NMOD	0
14	vascular	vascular	B-NP	JJ	B-protein	17	NMOD	0
15	endothelial	endothelial	I-NP	JJ	I-protein	17	NMOD	0
16	growth	growth	I-NP	NN	I-protein	17	NMOD	0
17	factor	factor	I-NP	NN	I-protein	24	NMOD	0
18	(	(	O	(	O	20	DEP	0
19	VEGF	VEGF	B-NP	NN	B-protein	20	DEP	0
20	)	)	O	)	O	17	NMOD	0
21	and	and	O	CC	O	24	NMOD	0
22	fibroblast	fibroblast	B-NP	NN	B-protein	24	NMOD	0
23	growth	growth	I-NP	NN	I-protein	24	NMOD	0
24	factor	factor	I-NP	NN	I-protein	28	NMOD	0
25	(	(	O	(	O	27	DEP	0
26	FGF	FGF	B-NP	NN	B-protein	27	DEP	0
27	)	)	O	)	O	24	NMOD	0
28	stimulation	stimulation	B-NP	NN	O	13	PMOD	17	stimulation
29	.	.	O	.	O	1	P	0

1	A	A	B-NP	DT	O	5	NMOD	0
2	specific	specific	I-NP	JJ	O	5	NMOD	0
3	VEGF	VEGF	I-NP	NN	B-protein	5	NMOD	0
4	receptor-2	receptor-2	I-NP	NN	I-protein	5	NMOD	0
5	inhibitor	inhibitor	I-NP	NN	O	6	SUB	0
6	demonstrated	demonstrate	B-VP	VBD	O	0	ROOT	0
7	the	the	B-NP	DT	O	8	NMOD	0
8	importance	importance	I-NP	NN	O	6	OBJ	0
9	of	of	B-PP	IN	O	8	NMOD	0
10	glycogen	glycogen	B-NP	NN	O	11	NMOD	0
11	metabolism	metabolism	I-NP	NN	O	15	NMOD	0
12	and	and	O	CC	O	15	NMOD	0
13	pentose	pentose	B-NP	NN	O	15	NMOD	0
14	cycle	cycle	I-NP	NN	O	15	NMOD	0
15	pathway	pathway	I-NP	NN	O	9	PMOD	0
16	.	.	O	.	O	6	P	0

1	Furthermore	Furthermore	B-ADVP	RB	O	4	VMOD	0
2	,	,	O	,	O	4	P	0
3	we	we	B-NP	PRP	O	4	SUB	0
4	showed	show	B-VP	VBD	O	0	ROOT	0
5	that	that	B-SBAR	IN	O	4	VMOD	0
6	glycogen	glycogen	B-NP	NN	B-protein	7	SUB	0
7	was	be	B-VP	VBD	O	5	SBAR	0
8	depleted	deplete	I-VP	VBN	O	7	VC	11	depleted
9	in	in	B-PP	IN	O	8	VMOD	0
10	a	a	B-NP	DT	O	13	NMOD	0
11	low	low	I-NP	JJ	O	13	NMOD	0
12	glucose	glucose	I-NP	NN	O	13	NMOD	0
13	medium	medium	I-NP	NN	O	9	PMOD	0
14	,	,	O	,	O	8	P	0
15	but	but	O	CC	O	8	VMOD	0
16	conserved	conserve	B-VP	VBN	O	8	VMOD	0
17	under	under	B-PP	IN	O	16	VMOD	0
18	hypoxic	hypoxic	B-NP	JJ	O	19	NMOD	0
19	conditions	condition	I-NP	NNS	O	17	PMOD	0
20	.	.	O	.	O	4	P	0

1	Finally	Finally	B-ADVP	RB	O	4	VMOD	0
2	,	,	O	,	O	4	P	0
3	we	we	B-NP	PRP	O	4	SUB	0
4	demonstrated	demonstrate	B-VP	VBD	O	0	ROOT	0
5	that	that	B-SBAR	IN	O	4	VMOD	0
6	direct	direct	B-NP	JJ	O	7	NMOD	0
7	inhibition	inhibition	I-NP	NN	O	18	SUB	0
8	of	of	B-PP	IN	O	7	NMOD	0
9	key	key	B-NP	JJ	B-protein	10	NMOD	0
10	enzymes	enzyme	I-NP	NNS	I-protein	8	PMOD	0
11	to	to	B-PP	TO	O	7	NMOD	0
12	glycogen	glycogen	B-NP	NN	O	13	NMOD	0
13	metabolism	metabolism	I-NP	NN	O	17	NMOD	0
14	and	and	O	CC	O	17	NMOD	0
15	pentose	pentose	B-NP	NN	O	17	NMOD	0
16	phosphate	phosphate	I-NP	NN	O	17	NMOD	0
17	pathways	pathway	I-NP	NNS	O	11	PMOD	0
18	reduced	reduce	B-VP	VBD	O	5	SBAR	18	reduced
19	HUVEC	HUVEC	B-NP	NNS	B-cell_type	22	NMOD	0
20	viability	viability	I-NP	NN	O	22	NMOD	0
21	and	and	I-NP	CC	O	22	NMOD	0
22	migration	migration	I-NP	NN	O	18	OBJ	14	migration
23	.	.	O	.	O	4	P	0

1	In	In	B-PP	IN	O	9	VMOD	0
2	this	this	B-NP	DT	O	3	NMOD	0
3	regard	regard	I-NP	NN	O	1	PMOD	0
4	,	,	O	,	O	9	P	0
5	inhibitors	inhibitor	B-NP	NNS	O	9	SUB	0
6	of	of	B-PP	IN	O	5	NMOD	0
7	these	these	B-NP	DT	O	8	NMOD	0
8	pathways	pathway	I-NP	NNS	O	6	PMOD	0
9	have	have	B-VP	VBP	O	0	ROOT	0
10	been	be	I-VP	VBN	O	9	VC	0
11	shown	show	I-VP	VBN	O	10	VC	0
12	to	to	I-VP	TO	O	13	VMOD	0
13	be	be	I-VP	VB	O	11	VMOD	0
14	effective	effective	B-NP	JJ	O	16	NMOD	0
15	antitumoral	antitumoral	I-NP	JJ	O	16	NMOD	0
16	agents	agent	I-NP	NNS	O	13	PRD	0
17	.	.	O	.	O	9	P	0

1	To	To	B-VP	TO	O	2	VMOD	0
2	sum	sum	I-VP	VB	O	7	VMOD	0
3	up	up	B-PRT	RP	O	2	VMOD	0
4	,	,	O	,	O	7	P	0
5	our	our	B-NP	PRP$	O	6	NMOD	0
6	data	datum	I-NP	NNS	O	7	SUB	0
7	suggest	suggest	B-VP	VBP	O	0	ROOT	0
8	that	that	B-SBAR	IN	O	7	VMOD	0
9	the	the	B-NP	DT	O	10	NMOD	0
10	inhibition	inhibition	I-NP	NN	O	14	SUB	0
11	of	of	B-PP	IN	O	10	NMOD	0
12	metabolic	metabolic	B-NP	JJ	O	13	NMOD	0
13	pathways	pathway	I-NP	NNS	O	11	PMOD	0
14	offers	offer	B-VP	VBZ	O	8	SBAR	0
15	a	a	B-NP	DT	O	20	NMOD	0
16	novel	novel	I-NP	JJ	O	20	NMOD	0
17	and	and	I-NP	CC	O	20	NMOD	0
18	powerful	powerful	I-NP	JJ	O	20	NMOD	0
19	therapeutic	therapeutic	I-NP	JJ	O	20	NMOD	0
20	approach	approach	I-NP	NN	O	14	OBJ	0
21	,	,	O	,	O	20	P	0
22	which	which	B-NP	WDT	O	20	NMOD	0
23	simultaneously	simultaneously	B-ADVP	RB	O	24	VMOD	0
24	inhibits	inhibit	B-VP	VBZ	O	22	SBAR	18	inhibits
25	tumor	tumor	B-NP	NN	B-cell_type	27	NMOD	0
26	cell	cell	I-NP	NN	I-cell_type	27	NMOD	0
27	proliferation	proliferation	I-NP	NN	O	30	NMOD	1	proliferation
28	and	and	O	CC	O	30	NMOD	0
29	tumor-induced	tumor-induced	B-NP	JJ	O	30	NMOD	17	induced
30	angiogenesis	angiogenesis	I-NP	NN	O	24	OBJ	3	angiogenesis
31	.	.	O	.	O	7	P	0

